AAV mini-dystrophin gene therapy for Duchenne muscular dystrophy: a phase 1b trial

Journal:

Nature Medicine

Published:

2025-06-27

DOI:

10.1038/s41591-025-03750-3

Affiliations:

4

Authors:

12

Go to article

Institutions	Authors	Share
Pfizer, United States of America (USA)	9.000000	0.75
The University of Utah (Utah), United States of America (USA)	1.000000	0.08
University of California, Los Angeles (UCLA), United States of America (USA)	1.000000	0.08
Duke University, United States of America (USA)	1.000000	0.08

Interested in Medical Biotechnology?